EBF3 HADDS Foundation
Mallory Schindler is a seasoned executive with extensive experience in healthcare education and operations. Currently serving as Co-Founder and President of the Board of Directors at EBF3 HADDS Foundation since February 2019, Mallory has held various senior leadership roles, including Chief Operating Officer at Evidence In Motion from June 2023 to January 2025, and Global Senior Vice President of Clinical Operations at Keypath Education from June 2018 to May 2023. Previous positions include Director-level roles at 2U, where responsibilities spanned student services for online graduate programs, and the Society of Nuclear Medicine and Molecular Imaging, focusing on professional education for a large membership base. Mallory's career also includes managerial roles at American Academy of Nursing and multiple universities, with a strong educational foundation holding a BA in Education, History, and Political Science, along with a Master of Arts in Healthcare Administration.
This person is not in the org chart
This person is not in any teams
EBF3 HADDS Foundation
Mission: To enhance the lives of people with HADDS through research, education, support and advocacy. Mantra: Impacting the world together, one story at a time. Vision: Raise educational awareness and funding for research so that every person with HADDS: -Has a supportive community -Is able to reach their full potential -Has access to the most current educational/therapy materials -Has access to the most current research Values: Ethical & Transparent: It is the Foundation’s priority to be ethically and financially responsible when advancing our mission in the areas of research, education, support and advocacy. Committed: We are nothing as an organization if we are not committing our energy, talents and resources consistently towards research and education. Commitment drives progress! Inclusive & Collaborative: Be ambassadors for inclusion, welcoming and facilitating an environment of hope, belonging and community for all impacted by HADDS globally.